News
Dianthus Therapeutics, Inc. (NASDAQ:DNTH), a clinical-stage biotechnology company listed on the Nasdaq Composite Russell 1000 ...
Fintel on MSN6d
LifeSci Capital Initiates Coverage of GlycoMimetics (CBIO) with Outperform RecommendationFintel reports that on June 18, 2025, LifeSci Capital initiated coverage of GlycoMimetics (NasdaqCM:CBIO) with a Outperform ...
Fintel on MSN6d
LifeSci Capital Downgrades Verve Therapeutics (VERV)Fintel reports that on June 18, 2025, LifeSci Capital downgraded their outlook for Verve Therapeutics (NasdaqGS:VERV) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback